SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-016418
Filing Date
2021-08-10
Accepted
2021-08-10 16:24:28
Documents
68
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fhtx-20210630.htm   iXBRL 10-Q 1081367
2 EX-10.1 fhtx-20210630xex101.htm EX-10.1 51880
3 EX-31.1 fhtx-20210630xex311.htm EX-31.1 9829
4 EX-31.2 fhtx-20210630xex312.htm EX-31.2 9808
5 EX-32.1 fhtx-20210630xex321.htm EX-32.1 4398
6 EX-32.2 fhtx-20210630xex322.htm EX-32.2 4383
  Complete submission text file 0001628280-21-016418.txt   5413360

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fhtx-20210630.xsd EX-101.SCH 39133
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fhtx-20210630_cal.xml EX-101.CAL 68436
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fhtx-20210630_def.xml EX-101.DEF 160680
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fhtx-20210630_lab.xml EX-101.LAB 488036
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fhtx-20210630_pre.xml EX-101.PRE 305751
12 EXTRACTED XBRL INSTANCE DOCUMENT fhtx-20210630_htm.xml XML 848312
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Filer) CIK: 0001822462 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39634 | Film No.: 211160255
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences